Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 269

1.

Glucosamine HCl as a new carrier for improved dissolution behaviour: effect of grinding.

Al-Hamidi H, Edwards AA, Mohammad MA, Nokhodchi A.

Colloids Surf B Biointerfaces. 2010 Nov 1;81(1):96-109. doi: 10.1016/j.colsurfb.2010.06.028. Epub 2010 Jul 6.

PMID:
20674291
2.

To enhance dissolution rate of poorly water-soluble drugs: glucosamine hydrochloride as a potential carrier in solid dispersion formulations.

Al-Hamidi H, Edwards AA, Mohammad MA, Nokhodchi A.

Colloids Surf B Biointerfaces. 2010 Mar 1;76(1):170-8. doi: 10.1016/j.colsurfb.2009.10.030. Epub 2009 Nov 11. Erratum in: Colloids Surf B Biointerfaces. 2010 Sep 1;79(2):535.

PMID:
19945828
3.

Effect of glucosamine HCl on dissolution and solid state behaviours of piroxicam upon milling.

Al-Hamidi H, Edwards AA, Douroumis D, Asare-Addo K, Nayebi AM, Reyhani-Rad S, Mahmoudi J, Nokhodchi A.

Colloids Surf B Biointerfaces. 2013 Mar 1;103:189-99. doi: 10.1016/j.colsurfb.2012.10.023. Epub 2012 Nov 5.

PMID:
23201737
4.

Solid state interaction of raloxifene HCl with different hydrophilic carriers during co-grinding and its effect on dissolution rate.

Garg A, Singh S, Rao VU, Bindu K, Balasubramaniam J.

Drug Dev Ind Pharm. 2009 Apr;35(4):455-70. doi: 10.1080/03639040802438365 .

PMID:
19048425
5.

Solid state and dissolution rate characterization of co-ground mixtures of nifedipine and hydrophilic carriers.

Friedrich H, Nada A, Bodmeier R.

Drug Dev Ind Pharm. 2005 Sep;31(8):719-28.

PMID:
16221606
6.

Investigation of intrinsic dissolution behavior of different carbamazepine samples.

Sehić S, Betz G, Hadzidedić S, El-Arini SK, Leuenberger H.

Int J Pharm. 2010 Feb 15;386(1-2):77-90. doi: 10.1016/j.ijpharm.2009.10.051. Epub 2009 Nov 10.

PMID:
19900519
7.

Evaluation of modified gum karaya as carrier for the dissolution enhancement of poorly water-soluble drug nimodipine.

Murali Mohan Babu GV, Prasad ChD, Ramana Murthy KV.

Int J Pharm. 2002 Mar 2;234(1-2):1-17.

PMID:
11839433
8.

The dissolution enhancement of piroxicam in its physical mixtures and solid dispersion formulations using gluconolactone and glucosamine hydrochloride as potential carriers.

Al-Hamidi H, Obeidat WM, Nokhodchi A.

Pharm Dev Technol. 2015 Jan;20(1):74-83. doi: 10.3109/10837450.2013.871029. Epub 2014 Jan 6.

PMID:
24392858
9.

Evaluation of physico-mechanical properties of drug-excipients agglomerates obtained by crystallization.

Maghsoodi M, Tajalli Bakhsh AS.

Pharm Dev Technol. 2011 Jun;16(3):243-9. doi: 10.3109/10837451003610837. Epub 2010 Feb 22.

PMID:
20175665
10.
11.

Preparation and solid-state characterization of bupivacaine hydrochloride cyclodextrin complexes aimed for buccal delivery.

Jug M, Maestrelli F, Bragagni M, Mura P.

J Pharm Biomed Anal. 2010 May 1;52(1):9-18. doi: 10.1016/j.jpba.2009.11.013. Epub 2009 Nov 18.

PMID:
20004541
12.

Carbamazepine/betaCD/HPMC solid dispersions. II. Physical characterization.

Koester LS, Mayorga P, Pereira VP, Petzhold CL, Bassani VL.

Drug Dev Ind Pharm. 2003 Feb;29(2):145-54.

PMID:
12648011
13.

Studies on the applicability of tamarind kernel powder as a carrier in the dissolution enhancement of poorly water soluble drug, celecoxib.

Babu GV, Gowrisankar V, Himasankar K, Murthy KV.

Boll Chim Farm. 2003 Mar-Apr;142(2):76-82.

PMID:
12705095
14.

Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.

Badr-Eldin SM, Elkheshen SA, Ghorab MM.

Eur J Pharm Biopharm. 2008 Nov;70(3):819-27. doi: 10.1016/j.ejpb.2008.06.024. Epub 2008 Jul 4.

PMID:
18655829
15.

Evaluation of supercritical fluid technology as preparative technique of benzocaine-cyclodextrin complexes--comparison with conventional methods.

Al-Marzouqi AH, Jobe B, Dowaidar A, Maestrelli F, Mura P.

J Pharm Biomed Anal. 2007 Jan 17;43(2):566-74. Epub 2006 Sep 28.

PMID:
17010552
17.

Effect of grinding with hydroxypropyl cellulose on the dissolution and particle size of a poorly water-soluble drug.

Yamada T, Saito N, Imai T, Otagiri M.

Chem Pharm Bull (Tokyo). 1999 Sep;47(9):1311-3.

PMID:
10517010
18.

A novel application of α-glucosyl hesperidin for nanoparticle formation of active pharmaceutical ingredients by dry grinding.

Tozuka Y, Imono M, Uchiyama H, Takeuchi H.

Eur J Pharm Biopharm. 2011 Nov;79(3):559-65. doi: 10.1016/j.ejpb.2011.07.006. Epub 2011 Jul 24.

PMID:
21820051
19.

The influence of various amphiphilic excipients on the physicochemical properties of carbamazepine-loaded microparticles.

Barakat NS, Elanazi FK, Almurshedi AS.

J Microencapsul. 2009 May;26(3):251-62. doi: 10.1080/02652040802305113. Epub 2008 Oct 20.

PMID:
18686144
20.

Solution-mediated phase transformation of anhydrous to dihydrate carbamazepine and the effect of lattice disorder.

Murphy D, Rodríguez-Cintrón F, Langevin B, Kelly RC, Rodríguez-Hornedo N.

Int J Pharm. 2002 Oct 10;246(1-2):121-34.

PMID:
12270615

Supplemental Content

Support Center